• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellipharmaceutics International Inc (OP:IPCIF)

0.1500 UNCHANGED
Last Price Updated: 10:52 AM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1500
Today's Range 0.1500 - 0.1500
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intellipharmaceutics Announces Downgrade to OTC Expert Market
June 14, 2024
Via ACCESSWIRE
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
March 13, 2024
Via ACCESSWIRE

Performance

More News

Read More
Intellipharmaceutics Announces Cease Trade Order
March 06, 2024
Via ACCESSWIRE
Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
February 26, 2024
Via ACCESSWIRE
Intellipharmaceutics International Inc. Announces Stock Option Grant
February 08, 2024
Via ACCESSWIRE
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
January 02, 2024
Via ACCESSWIRE
Intellipharmaceutics Announces Third Quarter 2023 Results
October 16, 2023
Via ACCESSWIRE
Intellipharmaceutics Reports Director Election Results
September 14, 2023
Via ACCESSWIRE
Intellipharmaceutics Announces Second Quarter 2023 Results
July 14, 2023
Via ACCESSWIRE
Intellipharmaceutics Announces Third Quarter 2022 Results
October 14, 2022
Via ACCESSWIRE
Intellipharmaceutics Signs an Exclusive License & Supply Agreement with Taro Pharmaceuticals Inc. for Desvenlafaxine Extended-Release Tablets
August 16, 2022
Via ACCESSWIRE
Intellipharmaceutics Announces Second Quarter 2022 Results
July 21, 2022
Via ACCESSWIRE
Intellipharmaceutics Announces Second Quarter 2022 Results
July 21, 2022
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2022, The Financial Statements Will be Filed By July 21, 2022
July 15, 2022
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Reports Director Election Results
May 27, 2022
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Announces First Quarter 2022 Results
April 14, 2022
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Reports Director Election Results
February 04, 2022
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene Keirstead
January 13, 2022
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Comments on Recent Trading Activity
December 22, 2021
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Announces Third Quarter 2021 Results
October 15, 2021
From Intellipharmaceutics International Inc.
Via AccessWire
Topics Bankruptcy Intellectual Property
Intellipharmaceutics Announces Closing of CAD$3.85 Million Non-Brokered Private Placement
April 22, 2021
From Intellipharmaceutics International Inc.
Via AccessWire
Intellipharmaceutics Announces First Quarter 2021 Results
April 14, 2021
From Intellipharmaceutics International Inc.
Via AccessWire
Topics Bankruptcy Intellectual Property

Frequently Asked Questions

Is Intellipharmaceutics International Inc publicly traded?
Yes, Intellipharmaceutics International Inc is publicly traded.
What exchange does Intellipharmaceutics International Inc trade on?
Intellipharmaceutics International Inc trades on the OTC Traded
What is the ticker symbol for Intellipharmaceutics International Inc?
The ticker symbol for Intellipharmaceutics International Inc is IPCIF on the OTC Traded
What is the current price of Intellipharmaceutics International Inc?
The current price of Intellipharmaceutics International Inc is 0.1500
When was Intellipharmaceutics International Inc last traded?
The last trade of Intellipharmaceutics International Inc was at 07/02/24 10:52 AM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap